stage II

I

I

1

with stage II ER+ eBC will
experience distant recurrence¹

~1

in

3

patients

I

I

stage II

In stage II (N0, N1) HR+/HER2- eBC

Today’s treatments leave this

risk largely unaddressed^2,3